Mechanisms of lymphocyte-mediated cytotoxicity in acute renal allograft reaction

Transplantation

Volumn 66, Issue 2, 1998, Pages 259-264

  Wever, Peter C ^a   Boonstra, Joke G ^b   Laterveer, Jolanda C ^b   Hack, C Erik ^c   Van Der Woude, Fokko J ^d   Daha, Mohamed R ^b   Ten Berge, Ineke J M ^a,e  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; GRANZYME B; PERFORIN; POLYCLONAL ANTIBODY;

ADULT; APOPTOSIS; ARTICLE; CELL INFILTRATION; CENTRIFUGE; CLINICAL ARTICLE; CYTOTOXICITY; FEMALE; GENE EXPRESSION; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; KIDNEY ALLOGRAFT; LIGAND BINDING; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

ACUTE DISEASE; ADULT; AGED; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; KILLER CELLS, LYMPHOKINE-ACTIVATED; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032558111     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199807270-00021     Document Type: Article

References (29)

1. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
2. Miltenburg AMM, Meijer-Paape ME, Daha ME, et al. Donor-specific lysis of human kidney proximal tubular epithelial cells by renal allograft-infiltrating lymphocytes. Transplantation 1989; 48: 296.
3. Kägi D, Vignaux F, Ledermann B, et al. Fas and perform pathways as major mechanisms of T-cell mediated cytotoxicity. Science 1994; 265: 528.
4. Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 1994; 370: 650.
5. Liu C-C, Walsh CM, Young JD-E. Perforin: structure and function. Immunol Today 1995; 16: 194.
6. Smyth MJ, Trapani JA. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today 1995; 16: 202.
7. Liu C-C, Young LHY, Young JD-E. Lymphocyte-mediated cytolysis and disease. N Engl J Med 1996; 335: 1651.
8. Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449.
9. Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996; 85: 817.
10. Kummer JA, Wever PC, Kamp AM, ten Berge RJM, Hack CE, Weening JJ. Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejection. Kidney Int 1995; 47: 70.
11. Robertson H, Wheeler J, Kirby JA, Morley AR. Renal allograft rejection-in situ demonstration of cytotoxic intratubular cells. Transplantation 1996; 61: 1546.
12. Sharma VK, Bologa RM, Li B, et al. Molecular executors of cell death-differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts. Transplantation 1996; 62: 1860.
13. Boonstra JG, van der Woude FJ, Wever PC, Laterveer JC, Daha MR, van Kooten C. Expression and function of Fas (CD95) on human renal tubular epithelial cells. J Am Soc Nephrol 1997; 8: 1517.
14. Detrisac CJ, Sens MA, Garvin AJ, Spicer SS, Sens DA. Tissue culture of human kidney epithelial cells of proximal tubular origin. Kidney Int 1984; 25: 383.
15. Coggi G, Dell'Orto P, Viale G. Avidin-biotin methods. In: Polak JM, van Noorden S, eds. Immunocytochemistry: modern methods and applications. Bristol: Wright, 1986: 54.
16. Kataoka T, Shinohara N, Takayama H, et al. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol 1996; 156: 3678.
17. Lowin B, Mattman C, Hahne M, Tschopp J. Comparison of Fas(APO-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes. Int Immunol 1996; 8: 57.
18. + memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J Exp Med 1995; 181: 1293.
19. Hall BM. Cells mediating allograft rejection. Transplantation 1991; 51: 1141.
20. Schulz M, Schuurman H-J, Joergensen J, et al. Acute rejection of vascular heart allografts by perforin-deficient mice. Eur J Immunol 1995; 5: 474.
21. Larsen CP, Alexander DZ, Hendrix R, Ritchie SC, Pearson TC, Fas-mediated cytotoxicity: an immunoeflector or immunoregulatory pathway in T cell-mediated immune responses? Transplantation 1995; 60: 221.
22. Lu X, Ledermann B, Borel JF. Survival of islet, grafts in perforin-deficient mice. Transplant Proc 1995; 27: 3262.
23. Selvaggi G, Ricordi C, Podack ER, Enverardi L. The role of the perform and Fas pathways of cytotoxicity in skin graft rejection. Transplantation 1996; 62: 1912.
24. Seino K, Kayagaki N, Bashuda H, Okumura K, Yagita H. Contribution of Fas ligand to cardiac allograft rejection. Int Immunol 1996; 8: 1347.
25. Kägi D, Ledermann B, Bürki K, Zinkernagel RM, Hengartner H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol 1996; 14: 207.
26. Liu C-C, Young LHY, Young JD-E. Lymphocyte-mediated cytolysis and disease. N Engl J Med 1996; 335: 1651.
27. Kirby JA, Forsythe JL, Proud G, Taylor RM. Renal allograft rejection: possible involvement of lymphokine-activated killer cells. Immunology 1989; 67: 62.
28. Ortiz-Arduan A, Danoff TM, Kalluri R, et al. Regulation of Fas and Fas ligand expression in cultured marine renal cells and in the kidney during endotoxemia. Am J Physiol 1996; 271: F1193.
29. Robertson H, Wheeler J, Thompson V, Johnson JS, Kirby FA, Morley AR. In situ lymphoproliferation in renal transplant biopsies. Histochem Cell Biol 1995; 104: 331.